Journal of Natural Medicines
·
2026
·
IF 2.6
Chen Peiyao,Wan Baolian,Yu Fei,Zhang Yanqiu,He Mengmeng,Wu Enyi,He Yanjun,Zhong Hui,Zhang Hao
Liver aging is a critical contributor to metabolic dysregulation and the development of various liver diseases. Currently, there is no approved therapy specifically targeting liver aging. The potential of medicinal and edible herbs in preventing and treating liver aging has attracted increasing attention. Accordingly, we constructed a self-built compound library containing 87 bioactive constituents isolated from these herbs. This study aimed to identify the potential compound capable of alleviating hepatic senescence from the constructed library and to elucidate the underlying mechanism. Isomucronulatol (Iso), a bioactive isoflavone isolated from Astragalus membranaceus , exhibited potential anti-hepatic senescence activity in a p21 promoter-driven luciferase reporter assay. Iso exhibited significant anti-hepatic senescence activity in H₂O₂-stimulated and doxorubicin (DOX)-stimulated HepG2 cells, as well as in mitomycin C (MC)-exposed AML12 cells, as evidenced by reduced SA-β-Gal positivity, downregulated p21 and p16 expression, and decreased secretion of SASP factors (IL-6, IL-1β, CCL2). In a D-galactose (D-gal)-induced mouse aging model, Iso treatment attenuated liver histological damage, lowered serum ALT and AST levels, and suppressed senescence markers in liver tissues. Transcriptomic and network pharmacology analyses revealed that Iso could activate Wnt/β-catenin signaling pathway to delay hepatic senescence. Mechanistically, Iso could facilitate nuclear accumulation of β-catenin by inhibiting GSK-3β acetylation, thereby restoring Wnt signaling. Collectively, these findings highlight Iso as a potential therapeutic agent against hepatic senescence. Graphical abstract
✓ 已验证
产品关联
DOI
高影响因子
FOOD AND CHEMICAL TOXICOLOGY
·
2026
·
IF 3.2
Rongli Sun,Kai Xu,Xiaoqin Li,Jiawei Huang,Daqin Wang,Yuepu Pu,Juan Zhang
Benzene causes SIRT6 inhibition which enhances glycolysis and lactate accumulation. • The increased lactate thus drives DSBs and cellular senescence in benzene toxicity. • SIRT6 regulates PRMT5 lactylation at lysine 240 (K240) via enzymes TIP60 and HDAC1. • Blocking PRMT5 K240 lactylation mitigates BQ-caused DNA damage and senescence. Benzene exposure induces hematotoxicity, partially through disrupted DNA damage repair. SIRT6 is a key regulator of both DNA repair and metabolism. While its connection to metabolic reprogramming and novel lactylation modifications in benzene toxicity remains unknown. Herein, we found decreased SIRT6 expression in the peripheral WBCs of benzene-exposed workers. Furthermore, mediation analysis identified SIRT6, p16, and serum γ-H2AX levels as mediators of the inverse relationship between urinary S-PMA and WBC counts. In vitro , benzoquinone (BQ) suppressed SIRT6, enhanced glycolysis and lactate production, and induced DNA double-strand breaks (DSBs) and senescence. SIRT6-knockdown models confirmed that SIRT6 deficiency exacerbates benzene-induced increase in glycolysis and lactate accumulation. Crucially, lactate reduction with DCA attenuated DSBs and cellular senescence in bone marrow cells, mitigating hematopoietic damage. Mechanistically, we identified PRMT5 as a novel lactylation target of SIRT6 at lysine 240 (K240), a process that SIRT6 regulated through the lactyltransferase TIP60 and delactylase HDAC1. Functional studies in K240-mutant cells demonstrated that blocking lactylation at this site alleviated BQ-induced DSBs and senescence. Our findings establish that SIRT6 deficiency drives a lactate-fuelled lactylation of PRMT5 at K240, impairing DNA repair and promoting hematopoietic stem cell senescence caused by benzene. This work elucidates a previously unrecognized metabolic-epigenetic axis in benzene toxicity and highlights the therapeutic potential of targeting glycolytic flux or specific lactylation events to combat chemical-induced hematological damage. Download: Download high-res image (245KB) Download: Download full-size image
✓ 已验证
产品关联
DOI
高影响因子
Materials Today Bio
·
2026
·
IF 11
Zhen-Zhen Wang,Lihua Cao,Zhenzhu Zhao,Mengke Zhao,Yanyan Lu,Yanhui Zhu,Weijie Xie,Ping Li,Siqi Liu,Xuejiao Li,Kang Yang,Xiaobo Sun
TLR4 activation and the cascade of neutrophil extracellular trap (NET) formation exacerbate excessive inflammation and organ damage in the pathogenesis of acute lung injury (ALI), yet effective pharmacological interventions remain unavailable. Nanoaggregates derived from natural products offer promising avenue by leveraging synergistic anti-inflammatory effects. In this study, we surprisingly discovered that leonurine and ursolic acid spontaneously self-assemble into nanoparticles (LUNP) through non-covalent interactions, achieving a drug loading capacity of 100%. The LUNP platform exhibits superior biophysical properties, including enhanced mucus penetration, pH-responsive drug release, improved cellular uptake, and prolonged retention within inflamed lung tissue. Mechanistically, LUNP ameliorates ALI by dampening TLR4/MyD88/NF-κB-driven inflammatory activation, thereby remodeling the microenvironment to limit NOX4-PAD4-mediated NET formation. Notably, inhalational LUNP exhibits outstanding biosafety with minimal off-target distribution. Overall, this work introduces a synergistic self-assembled nanoplatform for precise pulmonary intervention in ALI, showcasing its ability to safely and effectively orchestrate the coordinated modulation of multiple pathological pathways. In summary, by inhibiting both TLR4 activation and NET formation, the synergistic LUNP platform offers an efficient, safe, and easily accessible therapeutic strategy for ALI, providing a promising solution for clinical translation.
✓ 已验证
DOI
高影响因子
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
·
2026
·
IF 6.7
Li Muzi,Zhao Ruyang,Wang Qiqian,Chen Jing,Ma Xiaoyang,Wang Haoran,Li Jinlong
Di(2-ethylhexyl) phthalate (DEHP)
is a widespread environmental
pollutant with neurotoxicity, while lycopene (LYC) is a neuroprotective
dietary carotenoid. This study investigated whether LYC alleviates
DEHP-induced brain injury by regulating microglial activation and
cGAS-STING signaling. ICR mice were treated with LYC (5 mg/kg) and/or
DEHP (500 mg/kg) for 28 days, with results validated in BV2 cells.
In vivo, DEHP exposure impaired spatial learning and memory, triggered
neuronal degeneration, microglial activation and mitochondrial dysfunction,
increased 2 ′ 3 ′ -cGAMP production, and activated cGAS-STING
signaling. LYC supplementation markedly reversed these changes. Network
toxicology, molecular docking, and molecular dynamics suggested cGAS
as a potential LYC target. In vitro, MEHP-induced M1 polarization
was attenuated by LYC, and cGAS silencing verified the pathway’s
critical role in LYC’s protection. These findings indicate
that LYC alleviates DEHP-induced neural damage by maintaining mitochondrial
homeostasis and inhibiting cGAS-STING-mediated microglial activation,
providing a potential nutritional strategy for preventing brain damage
caused by environmental pollutants.
✓ 已验证
产品关联
DOI
高影响因子
FREE RADICAL BIOLOGY AND MEDICINE
·
2026
·
IF 8
Pingping Zhao,Binjing Pan,Xiaoyu Lv,Lihua Ma,Jingfang Liu
Non-enzymatic glycation is an important post-translational modification of proteins, ultimately forming advanced glycation end products (AGEs). In a high-glucose environment, the glycation degree of transferrin (Tf) increases, leading to elevated levels of AGE-modified transferrin (AGE-Tf), which reduces the binding capacity of Tf for iron. However, the role of AGE-Tf-associated iron dysregulation in diabetic nephropathy remains unclear. In this study, human podocytes were treated in vitro with AGE-Tf prepared by incubating Tf with 5.6 or 33.3 mM glucose (hereafter termed 5.6-Glc-AGE-Tf and 33.3-Glc-AGE-Tf, respectively) in combination with iron. Additionally, plasmids encoding Tf with mutations at three glycation sites (K206 A/K296 A/K534A; MT-Tf) or wild-type Tf (WT-Tf) were packaged into adeno-associated viral vectors and administered to diabetic rats. Compared with podocytes treated with 5.6-Glc-AGE-Tf, podocytes treated with 33.3-Glc-AGE-Tf exhibited reduced viability and greater oxidative stress. After ferric-citrate addition, intracellular Fe 2+ was also higher in the 33.3-Glc-AGE-Tf group than in the 5.6-Glc-AGE-Tf group. The 33.3-Glc-AGE-Tf group showed decreased GPX4, Nrf-2, and SLC7A11 expression and increased ACSL4 expression. In vivo, diabetic rats receiving an empty vector (DM-empty-vector) or a wild-type Tf vector (DM-WT-Tf-vector) exhibited higher renal AGE-Tf, Fe 2+ , and oxidative stress levels; lower nephrin and podocin expression; ferroptosis-related alterations; mesangial cell proliferation and matrix expansion; increased interstitial collagen deposition; and focal nodular sclerosis. These alterations were attenuated in diabetic rats receiving the glycation-resistant mutant Tf vector (DM-MT-Tf-vector). Deferoxamine (DFO) or TBHQ (an Nrf-2 activator) ameliorated oxidative stress, iron dysregulation, and ferroptosis in AGE-Tf-treated podocytes and in the kidneys of diabetic rats receiving the WT-Tf vector, whereas LY294002 (a PI3K/AKT pathway inhibitor) primarily alleviated oxidative stress. These findings identify AGE-Tf-associated iron dysregulation as a potential therapeutic target in diabetic kidney disease.
✓ 已验证
产品关联
DOI
高影响因子
INTERNATIONAL JOURNAL OF PHARMACEUTICS
·
2026
·
IF 6
Yijia Li,Jiaying Jin,Kemeng Chen,Siyu Yao,Long Yang,Yuxing Lin,Wenbing Dai,Hua Zhang,Bing He,Lei Miao,Qiang Zhang,Xueqing Wang
Pancreatic ductal adenocarcinoma (PDAC) is driven by KRAS mutations in over 90% of cases yet remains refractory to most therapies due to poor antigen delivery and a suppressive tumor microenvironment. To address these challenges, we developed an exosome‑augmented, epitope‑focused mRNA nanovaccine. First, we engineered a series-connected (SC) mRNA that condenses five immunodominant KRAS‑mutant epitopes (G12D, G12V, G12R and two other sequences) into a single open reading frame. This design minimizes non‑productive sequence and enhances antigen presentation compared to a conventional parallel-connected (PC) mixture of full‑length transcripts. Second, we cloaked β‑sitosterol LNPs with mature dendritic‑cell–derived exosomes (LNP@exo), endowing the particles with lymph‑node tropism and intrinsic adjuvanticity. The resulting mKRAS SC-LNP@exo triggered potent dendritic cell activation and Th1 cytokine release in vitro , rapidly accumulated in lymph nodes, and drove superior CD8⁺ T cell infiltration in a Pan02 tumor model. Remarkably, one‑third of mKRAS SC-LNP@exo treated mice achieved complete tumor regression without off‑target toxicity. These findings demonstrate that combining epitope‑condensed mRNA with exosome‑cloaked LNP delivery can convert “cold” KRAS‑mutant PDAC into an immunologically responsive tumor and provide a broadly applicable strategy for next‑generation mRNA cancer vaccines Download: Download high-res image (151KB) Download: Download full-size image
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
·
2026
·
IF 6.7
Lin Wujian,Li Xiance,Hu Wei,Zhao Xiaoyi,Wei Nana,Li Yuying,Bao Qi,Tian Cheng,Liu Weiwei,Chen Zitao,Mai Zilong,Zhao Shuhao,Zhu Yuanyuan,Zhu Guohui,Huang Haibo,Tang Zhonglin
In the livestock industry, intramuscular fat deposition
is a key
factor influencing meat tenderness and flavor. Although FOS (Fos proto-oncogene, AP-1 transcription factor subunit) has been
implicated in the regulation of cell proliferation and differentiation,
its differential roles in myogenic and adipogenic regulation remain
unclear. In this study, we revealed that FOS markedly
enhanced myogenic differentiation while inhibiting adipogenic differentiation
in muscle stem cells, indicating that it exerts distinct effects on
muscle development and intramuscular fat deposition. Mechanistically,
FOS modulated extracellular matrix signaling by regulating FAK and
PXN phosphorylation, acting as a molecular regulator between the muscle
and fat lineages. Furthermore, exon SNPs in FOS were
associated with slaughter weight and backfat thickness, and the mutant
genotypes weakened its antiadipogenic effect. Collectively, these
findings suggest that FOS is an important regulator
of myogenic and adipogenic differentiation and is a potential candidate
gene for the genetic improvement of meat quality traits.
✓ 已验证
产品关联
DOI
高影响因子
LIFE SCIENCES
·
2026
·
IF 6.4
Zhiyu Xi,Wang Zhang,Qiang Liu,Qingyan Wang,Yinbao Qi
Background The ketogenic diet (KD) is an established therapy for drug-resistant epilepsy, yet its antiseizure mechanisms remain unclear. This study investigates whether KD modulates lipid metabolism-related genes to exert antiseizure effects in a mouse model of temporal lobe epilepsy. Methods Chronic epilepsy was induced in adult mice via systemic kainic acid (KA). Epileptic mice were fed either a standard chow diet (CD) or KD. Seizure activity was monitored via electroencephalography and behavioral scoring. Temporal lobe transcriptomic changes were analyzed using RNA sequencing. The role of the peroxisome proliferator-activated receptor gamma (PPARγ) pathway was investigated in vivo and in primary hippocampal neurons using pharmacological agonists/antagonists and siRNA-mediated knockdown. Results KD-fed mice exhibited significantly reduced seizure frequency and severity compared to CD-fed controls. Transcriptomic analysis identified 41 differentially expressed lipid metabolism-related genes in the KD group. Perilipin 1 (Plin1) emerged as a top hub gene and was markedly upregulated in the hippocampus of KD-fed mice, associated with a significant increase in neuronal lipid droplet formation. In vitro, KD's effects were recapitulated by a PPARγ agonist and blocked by an antagonist, demonstrating that PPARγ mediates this transcriptional regulation. Knockdown of Plin1 in KA-treated neurons reduced lipid droplet formation and concurrently increased neuronal excitability (c-Fos expression), establishing a direct mechanistic link. Conclusion The ketogenic diet exerts antiseizure effects that may be related to activation of the PPARγ pathway, which upregulates Plin1 to promote lipid droplet formation in hippocampal neurons. This sequestration of fatty acids represents a novel mechanism for reducing neuronal excitability in chronic epilepsy.
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF CHEMICAL AND ENGINEERING DATA
·
2026
·
IF 2.4
Ke Yujiang,Huang Lemei,Che Chaohui,Chen Yihui,Zhan Junyong,Wu Kui
The solubility of 8-Hydroxyquinoline (8-HQ) was investigated
in
16 pure solvents, including eight alcohols (methanol, ethanol, n -propanol, isopropanol, n -butanol, isobutanol, n -pentanol, isopentanol), four ketones (2-butanone, 2-pentanone,
cyclopentanone, cyclohexanone), three esters (ethyl formate, methyl
acetate, ethyl acetate) and acetonitrile. The stability of the crystalline
form during dissolution was confirmed by X-ray powder diffraction
(XRPD), and the melting properties were characterized via differential
scanning calorimetry (DSC). Five thermodynamic models, namely the
modified Apelblat equation, the λ h model, the
nonrandom two-liquid (NRTL) model, the Wilson model, and the Yaws
model, were employed to correlate the experimental solubility data.
The fitting performance of each model was assessed using the coefficient
of determination ( R 2 ), relative average
deviation (RAD), and root-mean-square deviation (RMSD). The results
demonstrate that the molar solubility of 8-HQ increases monotonically
with temperature, and all five models provide satisfactory correlation
of the experimental data. Furthermore, mixing thermodynamic properties
(Gibbs free energy, enthalpy, and entropy) calculated from Wilson
model parameters reveal that mixing between 8-HQ and every solvent
is spontaneous and entropy-driven. This work provides a comprehensive
solubility database for 8-HQ, offering essential thermodynamic evidence
and model support for the design of high-yield crystallization processes.
✓ 已验证
产品关联
DOI
高影响因子
INDUSTRIAL CROPS AND PRODUCTS
·
2026
·
IF 6.4
Xue-Mei Yang,Xi-Ke Xu,Zhao-Ting Li,Xian-Peng Zu,Xin Chen,Hong-Yuan Dong,Wei-Dong Zhang,Bei Jiang,Yun-Heng Shen
First isolation of the polysaccharide from S. cannabina root. • It alleviates ethanol-induced cytotoxicity and oxidative stress in HepG2 cells. • SCPC-2 ameliorates ethanol metabolism by regulating ADH, ALDH, and CYP2E1 enzymes. • It activates the Keap1-Nrf2/HO-1 pathway to reduce oxidative stress and lipid peroxidation. • Provides a strategy for valorization of S. cannabina roots as functional ingredients. This study investigated the structural characteristics, conformational features, and hepatoprotective activity of a polysaccharide (SCPC-2) isolated from the roots of Sesbania cannabina , an underutilized industrial crop widely distributed in saline-alkaline regions. SCPC-2 exhibited an average molecular weight of 7.97 kDa and was composed mainly of mannose, galactose, rhamnose, glucose, arabinose, glucuronic acid, and galacturonic acid. Methylation analysis revealed that SCPC-2 contained diverse glycosidic linkages, including t-Man(p), t-Gal(p), t-Glc(p), and various branched residues, indicating a structurally complex architecture. NMR spectroscopy revealed characteristic oxygenated sugar-ring signals and representative H/C correlations, supporting the general carbohydrate structural features of SCPC-2. In vitro cell model assays demonstrated that SCPC-2 significantly improved the viability of ethanol-injured HepG2 cells. It reduced the levels of transaminases (ALT and AST) and the lipid peroxidation product MDA, while elevating the levels of antioxidants (SOD and GSH) and ethanol metabolism-related enzymes (ADH and ALDH). Mechanistic studies indicated that SCPC-2 alleviated ethanol-induced HepG2 cell damage by coordinately regulating ethanol metabolism and enhancing antioxidant defense via activation of the Keap1-Nrf2/HO-1 signaling pathway. These findings suggest that SCPC-2 may be a promising hepatoprotective agent, highlighting the potential for high-value utilization of S. cannabina roots.
✓ 已验证
产品关联
DOI
高影响因子
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
·
2026
·Vol. 1870
·期 11
·130988
·
IF 2.9
Jingxian Han,Lei Hua,Siqi Zhang,Bin Yang,Zhiying Li,Xiangguang Meng
Background Heart failure (HF) remains a leading cause of death worldwide. Stem cells represent a promising strategy for myocardial regeneration due to their differentiation potential and paracrine effects. This study investigated the effect of human pericardial fluid Sca-1 + /Nanog + cells Conditioned Medium (hPFCs-CM) on doxorubicin (DOX)-induced damage to AC16 cardiomyocytes using transcriptomic analysis. Methods Human AC16 cardiomyocytes were divided into Control (CON), DOX, DOXh, and hPFCs groups. Cell viability, cytotoxicity (LDH release), reactive oxygen species (ROS) levels, and apoptosis were assessed. Transcriptomic sequencing was performed on CON, DOX, and DOXh groups. MYH3 and IFI16 genes were knocked down using siRNA, followed by Western blot analysis of apoptosis. Results DOX significantly increased ROS and apoptosis compared with CON group ( P < 0.05), while hPFCs-CM attenuated these effects ( P < 0.05). RNA-seq identified 52 differentially expressed genes between DOX and DOXh groups (adj P < 0.05). Three target genes ( MYH3 , IFI16 , and KCTD14 ) were selected for RT-qPCR validation. Further functional assays revealed that MYH3 knockdown significantly potentiated the anti-apoptotic activity of hPFCs-CM ( P < 0.05), whereas IFI16 knockdown showed no significant effect. Conclusion hPFCs-CM effectively attenuated DOX-induced AC16 cardiomyocyte damage through MYH3, providing potential molecular targets for future mechanistic studies in myocardial injury treatment.
✓ 已验证
DOI
高影响因子
Advanced Healthcare Materials
·
2026
·
IF 11
Quan Zhou,Imran Ibrahim Shaikh,Jianfeng Wang,Tongjun Li,Xinrong Wang,Shekhar Singh,Ayesha Younas,Yaru Shi,Kwonseop Kim,Shuanghu Wang,Jian Xiao
Spinal cord injury (SCI) remains a major clinical challenge because the inflammatory and oxidative microenvironment drives secondary tissue damage. Although mollugin (Mol) possesses anti-inflammatory, antioxidant, and neuroprotective activities, its therapeutic application is limited by poor water solubility and rapid clearance. In this study, we developed a RVG-modified liposomal nanoplatform for targeted delivery of mollugin (Mol@Lip-RVG) as a novel therapeutic strategy for SCI. The Mol@Lip-RVG nanoplatform exhibited excellent biocompatibility, favorable physicochemical characteristics, and sustained drug release profile. In vitro studies demonstrated that Mol@Lip-RVG effectively downregulated pro-inflammatory mediators, promoted microglial polarization from the pro-inflammatory M1 phenotype toward the anti-inflammatory M2 phenotype, and significantly reduced reactive oxygen species production. In SCI mice, the RVG modification enabled efficient crossing of the BSCB and selective accumulation at the injury site through specific binding to nAChRs. This targeted delivery resulted in enhanced neuro-preservation and substantial improvement in motor function recovery, achieved through dual modulation of microglial reprogramming and attenuation of oxidative stress. Mechanistically, we demonstrated that Mol@Lip-RVG exerts its therapeutic effects is associated with inhibition of the NF-κB signaling pathway, thereby suppressing neuroinflammation. Collectively, these findings establish the Mol@Lip-RVG nanoplatform as a promising targeted therapeutic approach that addresses both the delivery challenges and complex pathophysiology of spinal cord injury.
✓ 已验证
产品关联
DOI
高影响因子